Mirum Pharmaceuticals, Inc.

NASDAQ:MIRM

41.08 (USD) • At close November 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q4
Assets:
Current Assets:
Cash & Cash Equivalents 233.245302.843286.326303.059297.22849.41928.00335.75955.26846.27231.3455.84491.93890.677142.08648.77883.04272.035139.95230.81441.81749.49351.963
Short Term Investments 45.126002.97132.72682.654123.716149.58869.68593.636125.201134.19131.913122.43689.73484.97166.29487.496104.6995.44542.37500
Cash and Short Term Investments 278.371302.843286.326306.03329.954132.073251.719185.347124.953139.908156.541190.034223.851213.113231.82133.749149.336159.531139.952126.25984.19249.49351.963
Net Receivables 60.4354.99967.96847.83435.32624.66123.99416.33713.997.8723.2670.400000000000
Inventory 20.43821.60622.31222.258.5096.6135.5656.9434.5241.581.513000000000000
Other Current Assets 8.5910.01710.93512.4659.7298.9878.9476.9293.7785.9085.2716.3714.5154.6424.534.4022.7392.9052.7033.0580.6660.2630.012
Total Current Assets 367.829389.465387.541388.579383.518172.334190.225215.556147.245155.268166.592196.805228.366217.755236.35138.151152.075162.436119.363129.31784.85849.75651.975
Non-Current Assets:
Property, Plant & Equipment, Net 9.861.1811.992.2152.482.1642.3452.0492.1942.3662.552.7242.8853.063.2423.3783.533.6773.7331.5721.4291.3170
Goodwill 00000000000000000000000
Intangible Assets 261.768257.443252.925258.33856.43757.69558.95445.03246.07218.48118.741900000000000
Goodwill and Intangible Assets 261.768257.443252.925258.33856.43757.69558.95445.03246.07218.48118.741900000000000
Long Term Investments 17.32500001001001001001004.98314.99714.9900006.5323.29227.316.10800
Tax Assets 00000-100-100-100-100-1000000000000000
Other Non-Current Assets 3.9723.8734.1651.511.153101.337101.382101.71101.7222.033101.7861.6411.4271.4261.2720.3360.1610.160.3240.0841.8710.4270
Total Non-Current Assets 292.925262.497259.08262.06360.07161.196162.681148.791149.988122.88128.05938.36219.3024.4864.5143.7143.69110.36727.34928.95619.4081.7440
Total Assets 660.754651.962646.621650.642443.588333.53352.906364.347297.233278.148294.651235.167247.668222.241240.864141.865155.766172.803146.712158.273104.26651.551.975
Liabilities & Equity:
Current Liabilities:
Account Payables 9.84215.9837.4167.36914.4466.448.6910.5488.1194.9439.1665.0035.385.6583.1515.1773.0243.2653.3512.6652.3482.3750.269
Short Term Debt 1.0720.3581.1041.0821.0640.9140.9310.7750.7520.7310.7110.690.6710.6530.6360.6160.530.5110.3970.3320.2210.0950
Tax Payables 00000000000000000000000
Deferred Revenue 00065.13100000030.72343.84720.77527.78113.41100000000
Other Current Liabilities 101.39489.56878.5441.08242.69341.48955.10840.07536.30328.8791.9960.8472.2020.931.26412.99913.0269.7729.3287.9128.5394.0532.18
Total Current Liabilities 112.308105.90987.06474.66458.20348.84364.72951.39845.17434.55342.59650.38729.02835.02218.46218.79216.5813.54813.07610.90911.1086.5232.449
Non-Current Liabilities:
Long Term Debt 307.242307.163306.421306.022306.7651.0551.2571.3111.5171.7131.9032.0882.2712.4522.6272.7882.9473.1033.2511.1241.241.190
Deferred Revenue Non-Current 00000141.71140.3510000000000000000
Deferred Tax Liabilities Non-Current 00000-141.71-140.3510000000000000000
Other Non-Current Liabilities 12.2164.2874.4660.8750.01142.482144.883142.341139.855132.95129.94126.296120.63250.88447.680.030.0310.0340.0360.037119.86859.8490
Total Non-Current Liabilities 319.458311.45310.887306.897306.775143.537146.14143.652141.372134.663131.843128.384122.90353.33650.3072.8182.9783.1373.2871.161121.10861.0390
Total Liabilities 431.766417.359397.951381.561364.978192.38210.869195.05186.546169.216174.439178.771151.93188.35868.76921.6119.55816.68516.36312.07132.21667.5622.449
Equity:
Preferred Stock 0000000000000000000158.273119.82659.84959.849
Common Stock 0.0050.0050.0050.0050.0040.0040.0040.0040.0030.0030.0030.0030.0030.0030.0030.0030.0030.0030.0020.0026.9916.9910.001
Retained Earnings -606.156-581.518-556.239-520.58-496.992-422.954-392.824-356.393-320.687-293.765-257.159-314.705-267.597-223.703-173.171-135.968-114.462-91.211-69.901-51.949-36.862-23.305-17.348
Accumulated Other Comprehensive Income/Loss -0.477-0.0131.644-1.4580.0760.136-0.217-0.413-0.202-0.131-0.035-0.006-0.01300.0830.1720.318-0.0240.1290.0980.028-59.8490
Other Total Stockholders Equity 835.616816.129803.26791.114-0.08563.9640.213526.099431.573402.825377.403371.104363.344357.583345.18256.048250.349247.35200.11939.779-117.933-59.5970.034
Total Shareholders Equity 228.988234.603248.67269.081-496.992141.15-392.824169.297110.687108.932120.21256.39695.737133.883172.095120.255136.208156.118130.349146.203-27.95-16.06242.536
Total Equity 228.988234.603248.67269.081-496.992141.15-392.824169.297110.687108.932120.21256.39695.737133.883172.095120.255136.208156.118130.349146.203-27.95-16.06242.536
Total Liabilities & Shareholders Equity 660.754651.962646.621650.642-132.014333.53-181.955364.347297.233278.148294.651235.167247.668222.241240.864141.865155.766172.803146.712158.273104.26651.544.985